Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Oger

Showing results (1-10 of 181) with videos related to

Pageof 19
Sort By:
La Revue Du Praticien|January 5, 2011
[Vascular risks and HRT]Emmanuel Oger
Fundamental & Clinical Pharmacology|January 18, 2018
EditorialEmmanuel Oger
La Revue Du Praticien|July 14, 2007
[Incidence and risk factors for venous thromboembolism]Emmanuel Oger, Dominique Mottier
Thrombosis Research|November 8, 2015
Emergency admissions for major haemorrhage associated with direct oral anticoagulantsJacques Bouget, Emmanuel Oger
La Revue Du Praticien|April 15, 2005
[Hormone therapy and risk for venous thromboembolism in postmenopausal women]Karine Lacut, Emmanuel Oger
La Revue Du Praticien|January 16, 2009
[Prescription and monitoring of anticoagulant therapies]Bruno Laviolle, Emmanuel Oger
Therapie|August 20, 2011
Knowledge and wishes of patients as regards vitamin K antagonists: a cross-sectional survey in Western Brittany, FranceBrendan Cornec, Nathalie Nabbe, Emmanuel Oger
Thrombosis Research|December 4, 2014
Emergency admissions for major haemorrhage associated with antithrombotics: a cohort studyJacques Bouget, Emmanuel Oger, Nathalie Nicolas
Internal and Emergency Medicine|February 3, 2022
Ground-level falls among nonagenarians: the impact of pre-injury antithrombotic therapyJacques Bouget, Alexia Jouhanny, Louis Soulat, et al.
Therapie|December 24, 2014
[Impact of a regional pharmacovigilance network on notification of adverse drug reactions: results at 3 years]Sylvie Picard, Elisabeth Polard, Emmanuel Oger, et al.
Pageof 19

Showing results (1-10 of 181) with videos related to

Sort By:
Pageof 19
La Revue Du Praticien|January 5, 2011
[Vascular risks and HRT]Emmanuel Oger
Fundamental & Clinical Pharmacology|January 18, 2018
EditorialEmmanuel Oger
La Revue Du Praticien|July 14, 2007
[Incidence and risk factors for venous thromboembolism]Emmanuel Oger, Dominique Mottier
Thrombosis Research|November 8, 2015
Emergency admissions for major haemorrhage associated with direct oral anticoagulantsJacques Bouget, Emmanuel Oger
La Revue Du Praticien|April 15, 2005
[Hormone therapy and risk for venous thromboembolism in postmenopausal women]Karine Lacut, Emmanuel Oger
La Revue Du Praticien|January 16, 2009
[Prescription and monitoring of anticoagulant therapies]Bruno Laviolle, Emmanuel Oger
Therapie|August 20, 2011
Knowledge and wishes of patients as regards vitamin K antagonists: a cross-sectional survey in Western Brittany, FranceBrendan Cornec, Nathalie Nabbe, Emmanuel Oger
Thrombosis Research|December 4, 2014
Emergency admissions for major haemorrhage associated with antithrombotics: a cohort studyJacques Bouget, Emmanuel Oger, Nathalie Nicolas
Internal and Emergency Medicine|February 3, 2022
Ground-level falls among nonagenarians: the impact of pre-injury antithrombotic therapyJacques Bouget, Alexia Jouhanny, Louis Soulat, et al.
Therapie|December 24, 2014
[Impact of a regional pharmacovigilance network on notification of adverse drug reactions: results at 3 years]Sylvie Picard, Elisabeth Polard, Emmanuel Oger, et al.
Pageof 19